Larvol Delta - Akari-Therapeutics-Announces-Acceleration-of-the-Phase-3-Clinical-Trial-of-Nomacopan-for-Treatment-of-Pediatric-HSCTTMA-into-Pivotal-Part-B-and-Addition-of-a-New-Pipeline-Program-Developing-Nomacopan-for-HSCTTMA-in-Adults

Coversin SC (nomacopan SC) - Akari Therap

https://www.globenewswire.com/news-release/2023/02/13/2606565/0/en/Akari-Therapeutics-Announces-Acceleration-of-the-Phase-3-Clinical-Trial-of-Nomacopan-for-Treatment-of-Pediatric-HSCT-TMA-into-Pivotal-Part-B-and-Addition-of-a-New-Pipeline-Program-.html

Feb 13, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next